|
Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
|
(In millions, except per share data) | ||||||
|
| ||||||
|
Business Outlook |
|
Three Months Ending July 1, 2017 | ||||
|
|
|
GAAP Measure |
|
Non-GAAP Adjustments |
|
Non-GAAP Measure |
|
Gross margin |
|
58.8% |
|
0.2% |
|
59.0% |
|
|
|
|
|
|
|
|
|
Operating expenses |
|
$92 |
|
$18 |
|
$74 - $75 |
|
|
|
|
|
|
|
|
|
Effective tax rate |
|
11.0% |
|
0.5% |
|
11.5% |
|
|
|
|
|
|
|
|
|
Diluted earnings per share - low |
|
$0.27 |
|
$0.41 |
|
$0.68 |
|
|
|
|
|
|
|
|
|
Diluted earnings per share - high |
|
$0.33 |
|
$0.41 |
|
$0.74 |
|
Silicon Laboratories Inc. | |||
|
Condensed Consolidated Balance Sheets | |||
|
(In thousands, except per share data) | |||
|
(Unaudited) | |||
|
| |||
|
|
April 1,
|
|
December 31,
|
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
$ 225,399 |
|
$ 141,106 |
|
Short-term investments |
396,327 |
|
153,961 |
|
Accounts receivable, net |
75,852 |
|
74,401 |
|
Inventories |
61,308 |
|
59,578 |
|
Prepaid expenses and other current assets |
54,360 |
|
61,805 |
|
Total current assets |
813,246 |
|
490,851 |
|
Long-term investments |
5,257 |
|
5,196 |
|
Property and equipment, net |
130,635 |
|
129,559 |
|
Goodwill |
288,629 |
|
276,130 |
|
Other intangible assets, net |
103,638 |
|
103,565 |
|
Other assets, net |
58,021 |
|
76,543 |
|
Total assets |
$1,399,426 |
|
$1,081,844 |
|
|
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
$ 43,781 |
|
$ 39,577 |
|
Accrued expenses |
47,416 |
|
50,100 |
|
Deferred income on shipments to distributors |
49,700 |
|
45,568 |
|
Income taxes |
4,396 |
|
4,450 |
|
Total current liabilities |
145,293 |
|
139,695 |
|
Long-term debt |
-- |
|
72,500 |
|
Convertible debt |
332,502 |
|
-- |
|
Other non-current liabilities |
42,797 |
|
42,691 |
|
Total liabilities |
520,592 |
|
254,886 |
|
Commitments and contingencies |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding |
-- |
|
-- |
|
Common stock – $0.0001 par value; 250,000 shares authorized; 42,348 and 41,889 shares issued and outstanding at April 1, 2017 and December 31, 2016, respectively |
4 |
|
4 |
|
Additional paid-in capital |
59,714 |
|
24,463 |
|
Retained earnings |
819,641 |
|
801,999 |
|
Accumulated other comprehensive income (loss) |
(525) |
|
492 |
|
Total stockholders' equity |
878,834 |
|
826,958 |
|
Total liabilities and stockholders' equity |
$1,399,426 |
|
$1,081,844 |
